Skip to main content
. 2022 Sep 20;4(3):302–312. doi: 10.1016/j.jaccao.2022.07.005

Figure 1.

Figure 1

The Permissive Cardiotoxicity Process

A schematic representation of the multidisciplinary approach to care of patients who develop or have the potential to develop cardiotoxicities while on cancer therapies. CV = cardiovascular.